000 01223 a2200337 4500
005 20250516172909.0
264 0 _c20140506
008 201405s 0 0 eng d
022 _a1744-8042
024 7 _a10.2217/pgs.13.149
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRoss, Stephanie
245 0 0 _aPharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran.
_h[electronic resource]
260 _bPharmacogenomics
_cOct 2013
300 _a1565-72 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aBenzimidazoles
_xtherapeutic use
650 0 4 _aClopidogrel
650 0 4 _aDabigatran
650 0 4 _aHumans
650 0 4 _aPharmacogenetics
650 0 4 _aPlatelet Aggregation Inhibitors
_xtherapeutic use
650 0 4 _aPolymorphism, Genetic
_xgenetics
650 0 4 _aTiclopidine
_xanalogs & derivatives
650 0 4 _aWarfarin
_xtherapeutic use
650 0 4 _abeta-Alanine
_xanalogs & derivatives
700 1 _aParé, Guillaume
773 0 _tPharmacogenomics
_gvol. 14
_gno. 13
_gp. 1565-72
856 4 0 _uhttps://doi.org/10.2217/pgs.13.149
_zAvailable from publisher's website
999 _c23136400
_d23136400